Phase 4 IOP Signals Associated With ILUVIEN®

Clinical trial NCT02424019 · COMPLETED

Trial details

NCT number: NCT02424019
Sponsor: Alimera Sciences
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Macular Edema (DME)

Start date: 2015-05-06
Primary completion: 2020-07-29
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.